Analyse CVS Health stock

Confirmed: The consensus price target of 91.11 EUR is only slightly below the current price of 91.53 EUR and is therefore clearly within the required plausibility range of ±25%.

Quantitative: CVS is trading at a P/E ratio of 15.33, what a defensive, diversified healthcare model does not seem excessive. After the strong recovery from the 52W low of EUR 51.13 to close to the 52W high of EUR 92.78, the paper is technically rated rather fair to slightly ambitious, but not obviously overextended. The market capitalization of 117.9 billion EUR is consistent with a mature large-cap profile. Historically, the range of the l...